CNIO reinforces AI and clinical research to get advances reach patients sooner

by CNIO - Centro Nacional de Investigaciones Oncológicas

The CNIO, Spain's leading cancer research center, focuses its scientific, technological, and human resources on the major challenges currently faced by cancer research.

Read more

Mónica López Fanarraga, through INNVAL, drives a technology to store DNA without refrigeration and reduce the environmental impact of biobanks

by Instituto de Investigación Marqués de Valdecilla

The initiative proposes a patented system for encapsulating nucleic acids in solid silica nanoparticles that enables DNA preservation at room temperature. The project will be developed and validated i...

Read more

La calidad del dato: el verdadero 'superpoder' detrás de la IA (Parte 1)

by NorayBio Software

Últimamente parece que todo se puede resolver con inteligencia artificial (IA). Y en parte es cierto; la IA puede ayudar a clasificar, predecir, detectar anomalías o resumir información con una efi...

Read more

From Donor to Discovery: Tebubio Facilitates Access to Rare Cancer Samples

by Tebubio

At Tebubio, they help researchers secure the biological materials they need reliably, compliantly, and without operational friction, so you can focus on discovery.

Read more

New discovery on brain metastasis reveals how tumors hijack immune cells to use them to their advantage

by CNIO - Centro Nacional de Investigaciones Oncológicas

A team from the Spanish National Cancer Research Centre has discovered a novel way in which tumor cells alter the brain to establish themselves and spread cancer.

Read more

An unprecedented mutation map reveals how amylin mutations influence type 2 diabetes

by IBEC - Institut de Bioenginyeria de Catalunya

A study by the Institute for Bioengineering of Catalonia (IBEC) has created a mutational map of the hormone amylin, the aggregation of which can damage pancreatic cells and lead to type 2 diabetes.

Read more

El Biobanco coordina la tramitación de muestras del ensayo fase 2 que utiliza oncovirus para revertir el mal pronóstico de pacientes con tumores cerebrales infantiles

by Cima Universidad de Navarra

El Biobanco Universidad de Navarra coordina la tramitación de muestras que se recogen en el ensayo clínico para pacientes con tumores cerebrales infantiles iniciado recientemente. Este estudio fase ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream